Therapeutic Proteins International, LLC (TPI) is a world-class developer and commercial manufacturer of finished biosimilar recombinant therapeutic protein products. TPI's products are manufactured in cGMP/BLA compliant facilities using proprietary
and patented technologies for both mammalian and bacterial expression systems at globally competitive cost. Located in the heart of Chicago, TPI is supplying the US FDA approved biosimilar cytokines and monoclonal antibodies globally to help reduce
the cost of treatment to patients worldwide.